These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 2180567)

  • 1. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
    Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
    Bigner SH; Humphrey PA; Wong AJ; Vogelstein B; Mark J; Friedman HS; Bigner DD
    Cancer Res; 1990 Dec; 50(24):8017-22. PubMed ID: 2253244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
    Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
    Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
    Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
    Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
    Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oncogene amplification in human neuroblastomas].
    Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14;18 translocation.
    Amakawa R; Fukuhara S; Ohno H; Tanabe S; Horii M; Matsuyama F; Kato I; Kakita T; Nagauchi O
    Cancer Res; 1990 Apr; 50(8):2423-8. PubMed ID: 2180570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
    Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
    Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.
    Crook T; Greenfield I; Howard J; Stanley M
    Oncogene; 1990 Apr; 5(4):619-22. PubMed ID: 2158040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification, expression and localization of the c-myc gene in BSp73 rat tumor cell lines.
    Birnbaum M; Spiess E
    Anticancer Res; 1988; 8(6):1185-91. PubMed ID: 2464334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
    Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D
    Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK; Sarafoff M; Kerler R; Rabes HM
    Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.